MEI Pharma Inc

NASDAQ:MEIP  
0.62
+0.01 (+1.84%)
Earnings Announcements

MEI Pharma Posts Q3 Loss Per Share Of 7 Cents

Published: 05/23/2022 21:59 GMT
MEI Pharma Inc (MEIP) - Mei Pharma Reports Third Quarter Fiscal Year 2022 Results and Operational Highlights.
Q3 Loss per Share $0.07.
Q3 Revenue $9.7 Million.
Q3 Earnings per Share View $-0.18, Revenue View $3.4 Million -- Refinitiv Ibes Data (analyst estimates).
We Remain Well Capitalized With $169 Million to Advance Our Pipeline and Continue Operations for Over Two Years.
Revenue is expected to be $4.78 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.